About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch

May 17, 2016

Click here to read more

Post navigation

Phosphagenics Signs Japanese License Option Agreement and R&D Alliance

Phosphagenics Expands License Agreement for Diclofenac Gel

Related Posts

Phosphagenics Initiates Cattle Study

June 1, 2016

AGM Chairman’s Address and CEO Presentation

May 28, 2018

Avecho’s Phase III Clinical Trial for Insomnia Commences

March 26, 2024March 26, 2024

Recent Posts

New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.